ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,204 | +106.7% | 65,514 | +193.2% | 0.00% | +100.0% |
| Q2 2023 | $31,061 | +94024.2% | 22,346 | +6.9% | 0.00% | 0.0% |
| Q1 2023 | $33 | -23.3% | 20,907 | +199.7% | 0.00% | -50.0% |
| Q4 2022 | $43 | -100.0% | 6,975 | -65.6% | 0.00% | 0.0% |
| Q3 2022 | $136,000 | +615.8% | 20,265 | +587.9% | 0.00% | – |
| Q2 2022 | $19,000 | -40.6% | 2,946 | -57.5% | 0.00% | – |
| Q1 2022 | $32,000 | +255.6% | 6,939 | +269.1% | 0.00% | – |
| Q4 2021 | $9,000 | -91.7% | 1,880 | -79.2% | 0.00% | -100.0% |
| Q3 2021 | $109,000 | +87.9% | 9,034 | +229.6% | 0.00% | +50.0% |
| Q2 2021 | $58,000 | +18.4% | 2,741 | +59.7% | 0.00% | +100.0% |
| Q1 2021 | $49,000 | +188.2% | 1,716 | +156.1% | 0.00% | 0.0% |
| Q4 2020 | $17,000 | -79.8% | 670 | -70.4% | 0.00% | 0.0% |
| Q3 2020 | $84,000 | -79.1% | 2,264 | -71.0% | 0.00% | -93.8% |
| Q2 2020 | $401,000 | +395.1% | 7,810 | +473.8% | 0.02% | +128.6% |
| Q4 2019 | $81,000 | +92.9% | 1,361 | +21.2% | 0.01% | +133.3% |
| Q3 2019 | $42,000 | +82.6% | 1,123 | +99.5% | 0.00% | +200.0% |
| Q1 2019 | $23,000 | +91.7% | 563 | +119.9% | 0.00% | 0.0% |
| Q4 2018 | $12,000 | -68.4% | 256 | -73.4% | 0.00% | -50.0% |
| Q2 2018 | $38,000 | +375.0% | 962 | +758.9% | 0.00% | +100.0% |
| Q1 2018 | $8,000 | -60.0% | 112 | -63.4% | 0.00% | -66.7% |
| Q4 2017 | $20,000 | -91.1% | 306 | -93.7% | 0.00% | -88.5% |
| Q2 2017 | $225,000 | – | 4,863 | +69371.4% | 0.03% | – |
| Q1 2017 | $0 | -100.0% | 7 | -99.5% | 0.00% | -100.0% |
| Q4 2016 | $19,000 | -63.5% | 1,525 | -70.9% | 0.00% | -60.0% |
| Q2 2016 | $52,000 | +5100.0% | 5,240 | +16275.0% | 0.01% | – |
| Q1 2016 | $1,000 | -66.7% | 32 | -76.5% | 0.00% | – |
| Q4 2015 | $3,000 | -95.3% | 136 | -94.9% | 0.00% | -100.0% |
| Q3 2015 | $64,000 | -7.2% | 2,679 | +215.5% | 0.01% | 0.0% |
| Q2 2015 | $69,000 | -17.9% | 849 | -6.5% | 0.01% | -40.0% |
| Q1 2015 | $84,000 | +8300.0% | 908 | +2354.1% | 0.01% | – |
| Q4 2014 | $1,000 | -80.0% | 37 | -81.5% | 0.00% | -100.0% |
| Q3 2014 | $5,000 | -80.8% | 200 | -88.5% | 0.00% | -66.7% |
| Q1 2014 | $26,000 | -3.7% | 1,745 | -12.8% | 0.00% | -40.0% |
| Q4 2013 | $27,000 | +1250.0% | 2,000 | +1900.0% | 0.01% | – |
| Q3 2013 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |